Cronos Group Announces Closing of Previously Announced $100 Million Bought Deal

Cronos Group Inc. (NASDAQ, TSX-V: CRON) ("Cronos Group" or the "Company") is pleased to announce that it has closed its previously announced bought deal public offering. A total of 10,420,000 common shares of Cronos Group (the "Shares") were sold at a price of $9.60 per Share for aggregate gross proceeds of approximately $100.0 million (the "Offering").

How Will The Halting Of The German Tendering Process Affect These Canadian LP's?

Although many investors are excited about Canada’s opportunity to capitalize on Germany’s emerging medical marijuana market, a court has halted the bidding process for firms to grow medical marijuana in Germany.

The medical marijuana market in Germany is expected to be massive due to the population and the fact that insurance will cover it. It looks like this market will take some time to really grow as the ruling comes as Germany struggles to meet demand for medical marijuana.

Peace Naturals Receives Dealer's License Allowing for the Exportation of New Product Categories

Cronos Group Inc. (TSXV: MJN) (OTC – Nasdaq Int'l Designation: PRMCF) ("Cronos Group" or the "Company") is pleased to announce that Peace Naturals Project Inc. ("Peace"), a licensed producer wholly owned by the Company, has just obtained a Dealer's License pursuant to the Controlled Drugs and Substances Act under Health Canada. This enables the Company to, through Peace, export medical cannabis extracts, including concentrated oil and resin products, internationally.